TerrAscend (TSNDF) Dividends Paid - Common (2022 - 2023)
TerrAscend (TSNDF) posted quarterly Dividends Paid - Common of -$7.0 million for Q4 2023, down 6863.11% year-over-year from $103000.0 in Q4 2022, and down 296.17% quarter-over-quarter from $3.6 million in Q3 2023.
TerrAscend (TSNDF) Dividends Paid - Common (2022 - 2023) Analysis & Trends
TerrAscend (TSNDF) has reported Dividends Paid - Common for 2 consecutive years, with -$7.0 million the latest figure, recorded in Q4 2023.
- In Q4 2023, Dividends Paid - Common fell 6863.11% year-over-year to -$7.0 million; the TTM figure through Dec 2023 stood at -$3.3 million (changed N/A YoY), while the FY2022 annual figure was $1.5 million, changed N/A from the prior year.
- Dividends Paid - Common declined to -$7.0 million in Q4 2023 per TSNDF's latest filing, from $3.6 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $3.6 million in Q3 2023 and bottomed at -$7.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 223.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -941.91 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 139.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | TerrAscend | 182.53 Mn | 140.41 Mn | 36.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -6.97 Mn |
| Dec 31, 2023 | -6.97 Mn |
| Sep 30, 2023 | 3.55 Mn |
| Sep 30, 2023 | 3.55 Mn |
| Dec 31, 2022 | 103,000.00 |
| Dec 31, 2022 | 103,000.00 |